Kura Oncology, Inc.
KURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $95 | $82 | $51 | $224 |
| Short-Term Investments | $454 | $549 | $607 | $503 |
| Receivables | $39 | $5 | $49 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $32 | $25 | $17 | $17 |
| Total Curr. Assets | $621 | $660 | $724 | $745 |
| Property Plant & Equip (Net) | $15 | $12 | $10 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $14 | $11 | $9 | $8 |
| Total NC Assets | $29 | $22 | $20 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $649 | $682 | $744 | $760 |
| Liabilities | – | – | – | – |
| Payables | $5 | $2 | $5 | $1 |
| Short-Term Debt | $6 | $5 | $4 | $4 |
| Tax Payable | $0 | $0 | $2 | $2 |
| Deferred Revenue | $49 | $49 | $41 | $24 |
| Other Curr. Liab. | $62 | $51 | $38 | $46 |
| Total Curr. Liab. | $121 | $107 | $90 | $79 |
| LT Debt | $14 | $15 | $16 | $12 |
| Deferred Rev, NC | $269 | $253 | $272 | $254 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $3 | $2 | $2 |
| Total NC Liab. | $286 | $270 | $290 | $268 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $10 | $10 | $7 |
| Total Liabilities | $407 | $377 | $379 | $347 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,093 | -$1,019 | -$953 | -$895 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $1,335 | $1,324 | $1,316 | $1,308 |
| Total Equity | $243 | $305 | $364 | $414 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $649 | $682 | $744 | $760 |
| Net Debt | -$76 | -$62 | -$32 | -$208 |